4-102570567-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003998.4(NFKB1):​c.407+3432A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.666 in 151,928 control chromosomes in the GnomAD database, including 34,124 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.67 ( 34124 hom., cov: 31)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.20

Publications

20 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.03).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.741 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB1NM_003998.4 linkc.407+3432A>G intron_variant Intron 6 of 23 ENST00000226574.9 NP_003989.2 P19838-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB1ENST00000226574.9 linkc.407+3432A>G intron_variant Intron 6 of 23 1 NM_003998.4 ENSP00000226574.4 P19838-2
NFKB1ENST00000505458.5 linkc.404+3432A>G intron_variant Intron 6 of 23 1 ENSP00000424790.1 P19838-1

Frequencies

GnomAD3 genomes
AF:
0.666
AC:
101117
AN:
151810
Hom.:
34083
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.748
Gnomad AMI
AF:
0.702
Gnomad AMR
AF:
0.560
Gnomad ASJ
AF:
0.674
Gnomad EAS
AF:
0.577
Gnomad SAS
AF:
0.716
Gnomad FIN
AF:
0.613
Gnomad MID
AF:
0.753
Gnomad NFE
AF:
0.650
Gnomad OTH
AF:
0.669
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.666
AC:
101201
AN:
151928
Hom.:
34124
Cov.:
31
AF XY:
0.663
AC XY:
49200
AN XY:
74258
show subpopulations
African (AFR)
AF:
0.748
AC:
31005
AN:
41458
American (AMR)
AF:
0.559
AC:
8528
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.674
AC:
2335
AN:
3466
East Asian (EAS)
AF:
0.577
AC:
2982
AN:
5170
South Asian (SAS)
AF:
0.717
AC:
3452
AN:
4814
European-Finnish (FIN)
AF:
0.613
AC:
6470
AN:
10560
Middle Eastern (MID)
AF:
0.755
AC:
222
AN:
294
European-Non Finnish (NFE)
AF:
0.650
AC:
44148
AN:
67902
Other (OTH)
AF:
0.673
AC:
1419
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1719
3439
5158
6878
8597
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
808
1616
2424
3232
4040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.654
Hom.:
4418
Bravo
AF:
0.663
Asia WGS
AF:
0.634
AC:
2205
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.36
DANN
Benign
0.39
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs230500; hg19: chr4-103491724; API